Meet our 2021 investors & pharma BD


Early life science investor confirmations listed below. 

3B Future Health Fund

415 Capital

AbbVie

Advent

Agilitas Private Equity

Alebrasca Group

Almi Invest

Alpha Leonis Partners

ALSA Ventures

Agilitas

Amana Global Partners

Apogee

Apollo Ventures

Apposite Capital

Arix Bioscience

Asabys Partners

Astrazeneca

AurorA Science

Bedrock Capital

Biotechnology Business Institute

BioVentures_logo

Bootstrap Europe

British Asia Technology Incubator

Canica Holding

Capital Family Office

CDD Ltd

Claris Ventures

Clavis Capital

Digital Networks plc

Droege Group

EIR Partners

EVX Ventures

Forbion

Forward Venture Capital

GEM

GGS Associates

Growth Capital

GU Ventures

Hadean Ventures

HealthCap

HKSTP

IAG

IHM-GBA

ImecXpand Fund

Indaco Venture Partners

Industrifonden

Innogest Capital

Innovestor Ventures

Investinor

Ignite Capital Partners

IPF Partners

JBG Capital

johnson-innovation

Julz & Co.

Kreos Capital

Kurma Partners

Leksell

Lifespan Investments

Longliv ventures

M Ventures

Medicxi

Melior Capital Management

MID ATLANTIC BIO ANGELS

MRL Ventures fund

MSD Inventing For Life

MVM Partners

Negma Group

New Rhein Healthcare Investors

Noaber Ventures

Novalis Biotech Acceleration

Novo Holdings

Novo Nordisk Foundation

NRW Bank

Optum Ventures

Oskare Capital

Outsized Ventures

Pfizer

Pharma Capital Partners

Proxima

Rejuveron

Remiges Ventures

Roivant Sciences

RYSE Asset Management

Sciety

Seedlink

SOTIO

Sunstone Life Science Ventures

Taiho Ventures

Tet Ventures

TVM Capital

Unicorn Capital Partner

UVM Health Network

Vækstfonden

Ventac Partners

Villgro

Voima Ventures

Wille Finance

WTH-Capital

XOventure

DOWNLOAD BROCHURE